-
1
-
-
0027996563
-
FK506 treatment of noninfectious uveitis
-
Ishioka M, Ohno S, Nakamura S, et al. FK506 treatment of noninfectious uveitis. Am J Ophthalmol, 1994, 118: 723-729.
-
(1994)
Am J Ophthalmol
, vol.118
, pp. 723-729
-
-
Ishioka, M.1
Ohno, S.2
Nakamura, S.3
-
2
-
-
0034808168
-
Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts
-
Sloper CM, Powell RJ, Dua HS. Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts. Ophthalmology, 2001, 108: 1838-1844.
-
(2001)
Ophthalmology
, vol.108
, pp. 1838-1844
-
-
Sloper, C.M.1
Powell, R.J.2
Dua, H.S.3
-
3
-
-
0023691846
-
FR-900520 and FR-900523, novel immunosuppressants isolated from a streptomyces II. Fermantation, isolation and physico-chemical and biological characteristics
-
Hatanaka H, Kino T, Miyata S, et al. FR-900520 and FR-900523, novel immunosuppressants isolated from a streptomyces II. Fermantation, isolation and physico-chemical and biological characteristics. J Antibiot, 1988, 11: 1592-1601.
-
(1988)
J Antibiot
, vol.11
, pp. 1592-1601
-
-
Hatanaka, H.1
Kino, T.2
Miyata, S.3
-
4
-
-
0027328928
-
Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye
-
Pleyer U, Lutz S, Jusko WJ, et al. Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye. Invest Ophthalmol Vis Sci, 1993, 34: 2737-2742.
-
(1993)
Invest Ophthalmol Vis Sci
, vol.34
, pp. 2737-2742
-
-
Pleyer, U.1
Lutz, S.2
Jusko, W.J.3
-
5
-
-
0034984424
-
Biodegradable polymers for ocular drug delivery
-
Kimura H, Ogura Y. Biodegradable polymers for ocular drug delivery. Ophthalmologica, 2001, 215: 143-155.
-
(2001)
Ophthalmologica
, vol.215
, pp. 143-155
-
-
Kimura, H.1
Ogura, Y.2
-
6
-
-
34247351705
-
-
Chinese source
-
Chinese source
-
-
-
-
7
-
-
0032845727
-
Analytical validation of the PRO-Trac II ELISA for the determination of tacroliums (FX506) in whole blood
-
MacFarlane G, Scheller D, Ersfeld DL, et al. Analytical validation of the PRO-Trac II ELISA for the determination of tacroliums (FX506) in whole blood. Clin Chem, 1999, 45: 1449-1458.
-
(1999)
Clin Chem
, vol.45
, pp. 1449-1458
-
-
MacFarlane, G.1
Scheller, D.2
Ersfeld, D.L.3
-
8
-
-
34247329571
-
-
Chinese source
-
Chinese source
-
-
-
-
9
-
-
34247343364
-
-
Chinese source
-
Chinese source
-
-
-
-
10
-
-
34247335116
-
-
Chinese source
-
Chinese source
-
-
-
-
11
-
-
0023243094
-
Biopharmaceutical aspects of FK-506
-
Venkataramanan R, Warty VS, Zemaitis MA, et al. Biopharmaceutical aspects of FK-506. Transplant Proc, 1987, 19 (Suppl 6): 30-35.
-
(1987)
Transplant Proc
, vol.19
, Issue.SUPPL. 6
, pp. 30-35
-
-
Venkataramanan, R.1
Warty, V.S.2
Zemaitis, M.A.3
-
12
-
-
0031239380
-
An HPLC/MS/MS assay for tacrolimus in patient blood samples correlation with results of an ELISA assay
-
Alak AM, Moy S, Cook M, et al. An HPLC/MS/MS assay for tacrolimus in patient blood samples correlation with results of an ELISA assay. J Pharm Biomed Anal, 1997, 16: 7-13.
-
(1997)
J Pharm Biomed Anal
, vol.16
, pp. 7-13
-
-
Alak, A.M.1
Moy, S.2
Cook, M.3
-
13
-
-
0029933674
-
Quantitative determination of tautomeric FK506 by reversed-phase liquid chromatography
-
Akashi T, Nefuji T, Yoshida M, et al. Quantitative determination of tautomeric FK506 by reversed-phase liquid chromatography. J Pharm Biomed Anal, 1996, 14: 339-346.
-
(1996)
J Pharm Biomed Anal
, vol.14
, pp. 339-346
-
-
Akashi, T.1
Nefuji, T.2
Yoshida, M.3
|